Our sister site, Drug Delivery Business News, reports that the company unveiled the device — which it touts as the world’s thinnest CGM — at last week’s 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam.
GS3 features an ultra-compact design and three-second activation. With a thickness of just 2.9 mm, China-based SiBionics compares its size to that of a small coin. It also weighs just 1.5 grams, which the company says makes it “almost unnoticeable when worn.”
SiBionics brings the GS3 CGM to the market at an interesting time as it remains embroiled in a patent battle with leading CGM maker Abbott. Last summer, The Hague said the company can’t distribute its CGMs in Germany, France, the Netherlands and Ireland.
Get the full story at our sister site, Drug Delivery Business News.
